Pedro P. Granadillo

Pedro P. Granadillo has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Haemonetics Corp, Noven Pharmaceuticals Inc and Dendreon Corp. Over a trading history stretching from 3 January 2006 to 18 June 2025, the count stands at 97 filings.

Both buying and selling appear: 6 purchases worth €284k, against 43 sales worth €7.3M. Netting one side against the other leaves €7.0M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 24 share grants and 19 option exercises.

The median purchase comes to €27k.

Most recently, on 18 July 2025, the filings show a share grant in Rocket Pharmaceuticals, Inc. The last insider purchase was made public on 6 November 2008, 6,561 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.